While China’s economic rebound stalls and the US economy holds steady, Invesco favours European and emerging market equities.
![](https://s34456.pcdn.co/wp-content/uploads/2021/07/Invesco_David-Chao-1-640x360.jpg.optimal.jpg)
While China’s economic rebound stalls and the US economy holds steady, Invesco favours European and emerging market equities.
Market conditions look supportive for developed market equities for the rest of 2021, with fixed income more likely to be effective for risk management, says Natixis Investment Managers.
Corporate earnings are recovering, and earnings and dividends growth are highly correlated, according to JP Morgan Asset Management (JPMAM).
This week FSA presents a quick comparison of two US equities products: the MFS Meridian US Value Fund and the Morgan Stanley US growth Fund.
Selected China A-shares and tech names will enable investors to weather inevitable bouts of higher inflation, geopolitical tensions and a strengthening US dollar, says Fidelity.
FSA compares two global equity products: the Dimensional Global Core Equity Fund and the Ninety One Global Strategic Equity Fund.
In a post-Covid Asia, capital investments in smart infrastructure, digitisation, automation and environmental imperatives will shape the equities landscape, says Pinebridge Investments.
This week FSA presents a quick comparison of two Greater China equities products: the Allianz All China Equity Fund and the JP Morgan Greater China Fund.
Investors should be allocating to Asia ex-Japan equities rather than developed market stocks over the next six- to 12-months, according to Deutsche Bank International Private Bank (IPB).
Investors need to understand how to combine the many ways to approach value investing and the various qualities of growth-oriented companies, according to a Franklin Templeton webinar.
Part of the Mark Allen Group.